Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
403.82
-9.10 (-2.20%)
Jan 2, 2026, 9:30 AM EST
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,189
Profits / Employee
$114,831
Market Cap
350.68B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Roche Holding AG News
- 6 days ago - What's Going On With Royalty Pharma Stock Wednesday? - Benzinga
- 7 days ago - Royalty Pharma Acquires Remaining Evrysdi Royalties From PTC Therapeutics - Nasdaq
- 7 days ago - Royalty Pharma buys remaining royalty interest in Roche drug Evrysdi - Seeking Alpha
- 8 days ago - Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones - Benzinga
- 13 days ago - Sanofi Makes $2.2 Billion Bet On Adult Vaccines With Dynavax Buy - Benzinga
- 14 days ago - US Drug Pricing Deal May Lead to Swiss Medicine Price Hikes - IBTimes
- 15 days ago - Roche (RHHBY) CEO Predicts Drug Price Increase in Switzerland - GuruFocus
- 15 days ago - Roche: FDA Approves Lunsumio VELO Under Accelerated Approval - Nasdaq